Stories about epilepsy medicines
On 3 April, BBC Newsnight reported that some medicines, including some for epilepsy, bipolar disorder and neuropathic pain, cannot be stockpiled.
This comes after the Health Secretary Matthew Hancock said in parliament that medical suppliers had been asked to stockpile an extra six-weeks’ worth of medicines. This is to ensure medicine supply continues in all Brexit scenarios.
This week, the Medicines and Healthcare products Regulatory Agency (MHRA) is running a campaign to raise awareness of reporting medicine side-effects.
A new US study has found that taking the medicine topiramate during pregnancy may cause an increased risk of birth defects.
Topiramate is an epilepsy medicine sometimes used to treat generalised tonic-clonic seizures or focal seizures. This medicine can also be used for other conditions, such as bipolar disorder.
Pharmaceuticals company Pfizer, which manufactures the epilepsy medicine phenytoin sodium capsules, has been fined a record £84.2 million by the Competition and Markets Authority (CMA). The company has been found to be breaking competition law by charging what the CMA said were 'excessive and unfair' prices in the UK for the medicine.